Sodium-Glucose Cotransporter 2 Inhibitors and the Risk of Fractures Among Patients With Type 2 Diabetes.

Abrahami, Devin; Douros, Antonios; Yin, Hui; Yu, Oriana H Y; Azoulay, Laurent

Abrahami, Devin; Douros, Antonios; Yin, Hui; Yu, Oriana H Y; Azoulay, Laurent.

Afiliação

Abrahami D; Centre for Clinical Epidemiology, Lady Davis Institute, Jewish General Hospital, Montreal, Canada.
Douros A; Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Canada.
Yin H; Centre for Clinical Epidemiology, Lady Davis Institute, Jewish General Hospital, Montreal, Canada.
Yu OHY; Department of Medicine, McGill University, Montreal, Canada.
Azoulay L; Institute of Clinical Pharmacology and Toxicology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.

Diabetes Care ; 42(9): e150-e152, 2019 09.

Article em En | MEDLINE | ID: mdl-31296645

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Risk_factors_studies Idioma: En Revista: Diabetes Care Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Canadá País de publicação: Estados Unidos

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google